Chinese biotech firms

New Business

Chinese drug makers strike a record US$136 billion in out-licensing deals in 2025

Chinese drug makers’ licensing deals more than doubled in 2025 from a year earlier to a record high, propelled by…

Read More »
New Business

Chinese biotech’s mega drug-licensing deals with multinationals surge on cost savings

A potential multibillion-dollar deal unveiled on Friday by CSPC Pharmaceutical Group is the latest in a growing number of agreements…

Read More »
Back to top button